Detection of Intrahepatic Hepatitis B Virus DNA and Correlation with Hepatic Necroinflammation and Fibrosis

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2004 Sep 15

PMID 15364969

Citations 10

Authors

Danny Ka-Ho Wong

Man-Fung Yuen

Eric Tse

Hejun Yuan

Simon Siu-Man Sum

Chee-Kin Hui

Ching-Lung Lai

Affiliations

Soon will be listed here.

Abstract

Assessment of intrahepatic hepatitis B virus (HBV) DNA levels in patients with chronic hepatitis B is important in understanding the natural history of the disease and designing antiviral therapy regimens. However, there is no standardized method for the measurement of intrahepatic HBV DNA levels. We describe a convenient novel method for the measurement of intrahepatic HBV DNA levels based on a modified COBAS Amplicor HBV Monitor test for HBV DNA measurement and real-time PCR beta-actin gene detection for human genomic DNA (hgDNA) quantitation. Fifteen hepatitis B e antigen (HBeAg)-positive patients, 26 patients positive for antibody to HBeAg (anti-HBe), and 8 control patients were recruited. The mean between-run coefficient of variation for the beta-actin real-time PCR assay was 15.4%. All eight control patients had undetectable intrahepatic and serum HBV DNA levels. All chronic hepatitis B patients had detectable intrahepatic HBV DNA levels, and all but one anti-HBe-positive patient had detectable serum HBV DNA levels. HBeAg-positive patients had higher median intrahepatic and serum HBV DNA levels than anti-HBe-positive patients (6,950 versus 676 HBV DNA copies/ng of hgDNA, respectively [P < 0.001] and 184 x 10(6) versus 6.65 x 10(6) copies/ml, respectively [P < 0.001]). The intrahepatic HBV DNA levels correlated strongly with the serum HBV DNA levels (r = 0.842; P < 0.001) and with the degree of fibrosis (P = 0.014). We conclude that the method that we describe is reliable and convenient for the measurement of intrahepatic HBV DNA levels and has potential clinical significance.

Citing Articles

Prevalence of HBV genotypes among patients attending Moi Teaching and Referral Hospital liver clinic.

Gikunyu C, Mbogori E, Kwena A, Maiyoh G PLoS One. 2024; 19(7):e0305753.

PMID: 38985789 PMC: 11236169. DOI: 10.1371/journal.pone.0305753.

Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B.

Wu R, Zhang Y, Xiang Y, Tang Y, Cui F, Cao J J Transl Med. 2018; 16(1):83.

PMID: 29615081 PMC: 5883874. DOI: 10.1186/s12967-018-1462-2.

Quantification of intrahepatic total HBV DNA in liver biopsies of HBV-infected patients by a modified version of COBAS Ampliprep/COBASTaqMan HBV test v2.0.

Salpini R, Piermatteo L, Gill U, Battisti A, Stazi F, Guenci T Med Microbiol Immunol. 2017; 206(4):295-299.

PMID: 28401351 DOI: 10.1007/s00430-017-0504-3.

Relationship between hepatitis B DNA viral load in the liver and its histology in patients with chronic hepatitis B.

Biazar T, Yahyapour Y, Hasanjani Roushan M, Rajabnia R, Sadeghi M, Taheri H Caspian J Intern Med. 2015; 6(4):209-12.

PMID: 26644894 PMC: 4649269.

Micro-RNA-122 levels in acute liver failure and chronic hepatitis C.

Dubin P, Yuan H, Devine R, Hynan L, Jain M, Lee W J Med Virol. 2014; 86(9):1507-14.

PMID: 24895202 PMC: 4930851. DOI: 10.1002/jmv.23987.

References

Yuen M, Yuan H, Hui C, Wong D, Wong W, Chan A . A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut. 2003; 52(3):416-9. PMC: 1773568. DOI: 10.1136/gut.52.3.416. View

Chu C, Hussain M, Lok A . Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology. 2002; 36(6):1408-15. DOI: 10.1053/jhep.2002.36949. View

Hamada H, Reddy P, KAKUNAGA T . Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A. 1985; 82(18):6133-7. PMC: 391006. DOI: 10.1073/pnas.82.18.6133. View

Lai C, Ching C, Tung A, Li E, Young J, Hill A . Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology. 1997; 25(1):241-4. DOI: 10.1002/hep.510250144. View

Moraleda G, Saputelli J, Aldrich C, Averett D, Condreay L, Mason W . Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol. 1997; 71(12):9392-9. PMC: 230243. DOI: 10.1128/JVI.71.12.9392-9399.1997. View

Gunther S, Fischer L, Pult I, Sterneck M, Will H . Naturally occurring variants of hepatitis B virus. Adv Virus Res. 1999; 52:25-137. DOI: 10.1016/s0065-3527(08)60298-5. View

Noborg U, Gusdal A, Pisa E, Hedrum A, Lindh M . Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test. J Clin Microbiol. 1999; 37(9):2793-7. PMC: 85382. DOI: 10.1128/JCM.37.9.2793-2797.1999. View

Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Villari D, de Franchis R . Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology. 2000; 31(2):507-12. DOI: 10.1002/hep.510310235. View

Weinberger K, Wiedenmann E, Bohm S, Jilg W . Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR). J Virol Methods. 2000; 85(1-2):75-82. DOI: 10.1016/s0166-0934(99)00154-8. View

10.

Josefsson A, Magnusson P, Ylitalo N, Sorensen P, Andersen P, Melbye M . Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 2000; 355(9222):2189-93. DOI: 10.1016/S0140-6736(00)02401-6. View

11.

Yuen M, Lai C . Natural history of chronic hepatitis B virus infection. J Gastroenterol Hepatol. 2000; 15 Suppl:E20-4. DOI: 10.1046/j.1440-1746.2000.02123.x. View

12.

Suzuki T, Higgins P, Crawford D . Control selection for RNA quantitation. Biotechniques. 2000; 29(2):332-7. DOI: 10.2144/00292rv02. View

13.

Brechtbuehl K, Whalley S, Dusheiko G, Saunders N . A rapid real-time quantitative polymerase chain reaction for hepatitis B virus. J Virol Methods. 2001; 93(1-2):105-13. DOI: 10.1016/s0166-0934(01)00260-9. View

14.

Lok A, Heathcote E, Hoofnagle J . Management of hepatitis B: 2000--summary of a workshop. Gastroenterology. 2001; 120(7):1828-53. DOI: 10.1053/gast.2001.24839. View

15.

Chen R, Piiparinen H, Seppanen M, Koskela P, Sarna S, Lappalainen M . Real-time PCR for detection and quantitation of hepatitis B virus DNA. J Med Virol. 2001; 65(2):250-6. DOI: 10.1002/jmv.2027. View

16.

Sturzenbaum S, Kille P . Control genes in quantitative molecular biological techniques: the variability of invariance. Comp Biochem Physiol B Biochem Mol Biol. 2001; 130(3):281-9. DOI: 10.1016/s1096-4959(01)00440-7. View

17.

Chien R, Yeh C, Sheen I, Chiou H, Chu C, Liaw Y . Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002; 35(6):1522-7. DOI: 10.1053/jhep.2002.33638. View

18.

Lopez V, Bourne E, Lutz M, Condreay L . Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels. J Clin Microbiol. 2002; 40(6):1972-6. PMC: 130700. DOI: 10.1128/JCM.40.6.1972-1976.2002. View

19.

Yuen M, Sablon E, Yuan H, Hui C, Wong D, Doutreloigne J . Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus. J Infect Dis. 2002; 186(9):1335-8. DOI: 10.1086/344327. View

20.

Knodell R, Ishak K, Black W, Chen T, Craig R, Kaplowitz N . Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1(5):431-5. DOI: 10.1002/hep.1840010511. View